Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers September 2, 2014
Pharmacy Choice - August 2014 Newsletter - September 2, 2014

Pharmacy Choice Newsletter - August 2014

The Pharmacy Spotlight - August 2014
August 7, 2014
Volume 16, Issue 8
Forward to a Friend
News Pharmacy Careers Resources Education Business Marketplace Login
This newsletter is sponsored by:
Rite Aid
Industry Headlines
08/04 – Studies in the Area of Fatty Liver Reported from Toranomon General Hospital
08/01 – Mobile Health, Big Data, and Antimicrobial Resistance Take Center Stage at the 2014 AACC Annual Meeting & Clinical Lab Expo
08/01 – FDA Approves Boehringer Ingelheim's Striverdi Respimat (olodaterol) Inhalation Spray for Maintenance Treatment of COPD
07/30 – Penn Researchers Find Naltrexone May Be Effective in Diminishing Impulse Control Disorders in Parkinson's Disease Patients
FDA Resources
Generic Drug Approvals
Paragraph IV Patent Certifications
News Releases
Upcoming Meetings
Office of Generic Drugs
FDA Drug Shortages

Quick Poll

How familiar are you with the new class of drugs, PAR-1 Antagonists?

Completely unfamiliar
Somewhat unfamiliar
Very familiar

Want to fill out the poll?
Hot Pharmacy Jobs
Staff Pharmacist
Fred's Stores of Tennessee, Inc
Monroeville, AL
Fred's Stores of Tennessee, Inc
UNM Hospitals
Albuquerque, NM
UNM Hospitals
PharMEDium Servies LLC
Cleveland, MS
PharMEDium Servies LLC
Travel opportunities for Hospital and Retail Pharmacists
Rx Pro Health
Statewide, CA

Choose from Pharmacy Jobs Nationwide with Rx Pro Health. Apply Now!
August Disease Focus

Overactive Bladder: Diagnosis and Treatment Guidelines
by Gina D. Moore, PharmD, MBA

Non-neurogenic overactive bladder (OAB) is characterized by the presence of urinary urgency, which is usually accompanied by urinary frequency and nocturia, with or without urinary incontinence, in the absence of infection or other pathology.1 Patients typically report… Read More
Hot Topic

New Thrombin Antagonist for Acute Coronary Syndrome
Darrell Hulisz, RPh, PharmD, Associate Professor, CWRU, School of Medicine and
Beth Cuiksa Doctor of Pharmacy Candidate, ONU College of Pharmacy

Vorapaxar (Zontivity®) is a protease activated receptor (PAR) type I (thrombin receptor) antagonist that has been approved by the FDA for the reduction of thrombotic cardiovascular events in patients… Read More
Last Month's Poll

How familiar are you with oral allergic desensitization as an alternative to allergy shots?

Very Familiar- 50%
Somewhat Familiar - 18.9%
Completely Unfamiliar - 31%
Continuing Education for Pharmacists
Enroll now at for the latest online Live and Enduring Continuing Education.
Inexpensive, easy to access, and excellent content all define the RxSchool Live experience!
Live On-line Webinars
Treatment and Management of Osteoporosis
Tuesday, August 12, 2014 - 6:00 PM ET, 2.0 credit hours
Efficacy vs. Safety: Treating BPH & Incontinence in the Elderly
Wednesday, August 13, 2014 - 7:00 PM ET, 2.0 credit hours
NEW! Adult Immunizations: A Guide for Pharmacists, Techs & NPs
Sunday, August 17, 2014 - 7:00 PM ET, 2.0 credit hours
RxSchool is accredited by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education.
Featured distance
Complementary and Alternative Medicine Part I
ACPE Pharmacist UPN#: 0372-0000-13-029-H04-P
ACPE Technician UPN#: 0372-0000-13-029-H04-T
Credits: 8 credit hours
Release Date: December 4, 2013
Expiration Date: December 4, 2016
Fee: $45.00
Audience: Pharmacists, Pharmacy Technicians
For more information,
visit the Course Information Page
RXSchool is accredited by the Accreditation
Council for Pharmacy Education as a provider
of continuing pharmacy education.

©2014 Pharmacy Choice (PC) - All rights reserved.
425 S. Cherry St. Suite 200 | Denver, Colorado 80246
Important Notice: The information contained in this newsletter is intended as an informational resource only. View our full disclaimer.
Previous Newsletters
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013

Be seen by thousands of industry eyes.
Advertise in the Pharmacy Choice Newsletter.

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement